Canadian Guidelines on Pharmacotherapy for Disruptive and Aggressive Behaviour in Children and Adolescents with Attention-Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, or Conduct Disorder
Daniel Gorman(University of Toronto), Tamara Pringsheim(University of Calgary), Kate Cochrane-Brink(University of Toronto), Khrista Boylan(McMaster University), Roxanne Goldade(University of Calgary), Andrea Murphy(Dalhousie University), David M. Gardner(Dalhousie University), Judy Ustina(University of Alberta), Margaret Steele(Western University), Paul R Soper, Mark Feldman(University of Toronto), Stacey A Bélanger(Canadian Paediatric Society)
Cited by 92
Related Papers
Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice
|Journal of Neuroscience|2010|574
Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis
|PLoS Genetics|2008|463
Screen time and young children: Promoting health and development in a digital world
|Paediatrics & Child Health|2017|398
Comorbidity of internalizing disorders in children with oppositional defiant disorder
|European Child & Adolescent Psychiatry|2007|262